Secondary Neoplasm — Trials

Secondary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,666 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 437 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07472322	ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1	not yet recruiting	Phase 1 / Phase 2	31	University of Wisconsin, MadisonOTHER	1	Sep 29, 2026	clinicaltrials
NCT07574541	Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance	not yet recruiting	Phase 2	52	National Cancer Institute (NCI)NIH	1